Latest filing published 24 Feb 2026 for Dr. Lal Path Labs Ltd., €14k.
Filing timeline
BuySaleAbhishek Aggarwal: trading record in brief
Abhishek Aggarwal (chief executive) discloses dealings in Dr. Lal Path Labs Ltd. to SEBI (PIT + SAST). The record holds 21 filings, for trades running from 16 August 2021 to 24 February 2026.
No open-market purchase appears, only 11 sales worth €214k. The rest of the record consists of 10 share grants.
Most recently, on 24 February 2026, the filings show a share grant worth €14k in Dr. Lal Path Labs Ltd. Filings reach the SEBI (PIT + SAST) feed a median of 1 day after the trade. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Abhishek Aggarwal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,500 shares@ ₹1,026.25075.7% of flowEquity SharesSEBI:fbbdfb416836614c2045b4fde14279f6c6b90cf2Canonical exit: 25 May 2026 (T+90)
- 1,750 shares@ ₹1,453.009.5% of flowEquity SharesSEBI:af7d6c0111386e0ac314f4271d2e5ad10b4c6d89
- 500 shares@ ₹10.000.0% of flowEquity SharesSEBI:f098e2394b24980b42ea2ded21b8858748b54b54Canonical exit: 6 Nov 2025 (T+90)
- 375 shares@ ₹10.000.0% of flowEquity SharesSEBI:6512eb6373129b88b25d64b6f2781c253ae94e02Canonical exit: 15 Sept 2025 (T+90)
- 625 shares@ ₹3,370.409.0% of flowEquity SharesSEBI:a10c1fd816769edfa9e07eff639fa652b0b9b0af
- 400 shares@ ₹3,418.555.8% of flowEquity SharesSEBI:f2e045385d1eb7bd5c539ad138ff89bd551d1056
- 375 shares@ ₹3,382.365.4% of flowEquity SharesSEBI:e5b9cca0a613764bb630999c5bf8242d133ce4e5
- 375 shares@ ₹3,323.85075.3% of flowEquity SharesSEBI:73b33f11ca7c2cd9dcdcd089aeaaa70ed864d537
- 625 shares@ ₹1,308.96483.5% of flowEquity SharesSEBI:13a0881579a14330ec416bf7308229f064907b86Canonical exit: 21 Nov 2024 (T+90)
- 475 shares@ ₹3,372.10536.8% of flowEquity SharesSEBI:e298bcdcc494f4abf0f18835b4dda924f3a12799
- 1,625 shares@ ₹453.08863.1% of flowEquity SharesSEBI:593689cc408fc45d3c32cdaa52a887e539daa12dCanonical exit: 18 Nov 2024 (T+90)
- 375 shares@ ₹3,273.90935.3% of flowEquity SharesSEBI:559c19649a554fe0962edfb654fa2c2517d081b8
- 975 shares@ ₹3,246.037913.6% of flowEquity SharesSEBI:451a1e9310cb7c60016d3a1543443e632aefe090
- 375 shares@ ₹1,930.05073.1% of flowEquity SharesSEBI:c0bd56948f37b859348095614c9b6b2c8b9a4d6cCanonical exit: 11 Nov 2024 (T+90)
- 900 shares@ ₹10.000.0% of flowEquity SharesSEBI:a95d64f9f2ffb2f5cb976426c2de935757771e26Canonical exit: 16 Jun 2024 (T+90)
- 375 shares@ ₹10.000.0% of flowEquity SharesSEBI:5e31edb324ca5e10f01935f34e235dbf4fa84271Canonical exit: 11 Mar 2024 (T+90)
- 900 shares@ ₹2,713.912210.8% of flowEquity SharesSEBI:73fd36acfce94088036207d009a61870db4e2a3d
- 450 shares@ ₹10.000.0% of flowEquity SharesSEBI:f07234d792d01dcba0d527d2f45a0fd5b23146caCanonical exit: 28 Dec 2022 (T+90)
- 600 shares@ ₹2,578.077.7% of flowEquity SharesSEBI:5214efff9fb439c1d78a1a1fc27e2dacc929982a
- 300 shares@ ₹3,965.36670.0000% mcap99.4% of flowEquity SharesSEBI:c4e9958db1fa6edc0295d1f9e808a496ee5f3db8
- 675 shares@ ₹10.000.0000% mcap0.6% of flowEquity SharesSEBI:cb7140b4e3f9bd47301894d4589915282b3179f0Canonical exit: 14 Nov 2021 (T+90)
21 of 21 declarations
